Regression and progression of valvulopathy associated with fenfluramine and phentermine

被引:7
作者
Dahl, CF [1 ]
Allen, MR [1 ]
机构
[1] Utah Valley Reg Med Ctr, Provo, UT 84604 USA
关键词
D O I
10.7326/0003-4819-136-6-200203190-00018
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:489 / 489
页数:1
相关论文
共 3 条
[1]
Dahl Charles F., 1999, Journal of the American College of Cardiology, V33, p549A
[2]
The progression of fenfluramine-associated valvular heart disease assessed by echocardiography [J].
Mast, ST ;
Jollis, JG ;
Ryan, T ;
Anstrom, KJ ;
Crary, JL .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (04) :261-266
[3]
Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy - A randomized, double-blind, placebo-controlled trial [J].
Weissman, NJ ;
Panza, JA ;
Tighe, JF ;
Gwynne, JT .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (04) :267-273